Bisadenosine compounds as adenosine A2A receptor agonists

Details for Australian Patent Application No. 2007241347 (hide)

Owner Novartis AG

Inventors Taylor, Roger John; Fairhurst, Robin Alec

Agent Davies Collison Cave

Pub. Number AU-A-2007241347

PCT Pub. Number WO2007/121924

Priority 0607950.3 21.04.06 GB

Filing date 19 April 2007

Wipo publication date 1 November 2007

International Classifications

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A61K 31/52 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

23 October 2008 PCT application entered the National Phase

  PCT publication WO2007/121924 Priority application(s): WO2007/121924

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007241369-Means for inhibiting the expression of CD31

2007241346-Purine derivatives as A2A receptor agonists